Form 4: Cardlytics Executive Lynton Nicholas Hollmeyer Reports Stock Transactions
SEC Form 4
Cardlytics' Chief Legal & Privacy Officer, Nicholas Hollmeyer Lynton, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On April 1, 2025, Nicholas Hollmeyer Lynton, Chief Legal & Privacy Officer of Cardlytics, Inc., reported transactions involving Cardlytics' common stock.
- These transactions included the vesting of restricted stock units (RSUs) and the subsequent sale of shares to satisfy tax withholding obligations.
- Specifically, 10,629, 581, and 1,578 RSUs vested, converting into common stock.
- Following the vesting, 5,754 shares were sold at a weighted average price of $1.806 per share.
- After these transactions, Lynton directly owns 101,740 shares of Cardlytics common stock, 42,518 restricted stock units from the first RSU award, 2,325 restricted stock units from the second RSU award, and 7,890 restricted stock units from the third RSU award.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing is a standard disclosure of stock transactions by an executive. The sale of shares is explicitly stated to be for tax obligations, mitigating potential negative interpretations.
Positives
- The vesting of RSUs indicates that Lynton is meeting the conditions of his equity compensation plan, which is tied to his continued service to the company.
Negatives
- The sale of shares, even if for tax obligations, could be perceived negatively by some investors if they interpret it as a lack of confidence in the company's future prospects, although the filing explicitly states the sale was solely for tax obligations.
Risks
- Executive stock sales, even for tax purposes, can sometimes create short-term price volatility.
Industry Context
Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. Investors often monitor these filings to gain insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders, potentially causing slight price fluctuations due to the sale of shares.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | 25% of shares under the second RSU award vested. |
| 07/01/2023 | 25% of shares under the third RSU award vested. |
| 07/01/2024 | First vesting date for the first RSU award. |
| 10/01/2024 | Second vesting date for the first RSU award. |
| 01/01/2025 | Third vesting date for the first RSU award. |
| 04/01/2025 | Date of RSU vesting and stock sale transactions. |
| 04/02/2025 | Date of stock sale transactions. |
| 07/01/2025 | Fifth vesting date for the first RSU award. |
| 10/01/2025 | Sixth vesting date for the first RSU award. |
| 01/01/2026 | Seventh vesting date for the first RSU award. |
| 04/01/2026 | Final vesting date for the first RSU award. |
Keywords
Cardlytics, insider trading, Form 4, Lynton, RSU, stock options, executive compensation, stock sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.